Recorded on: November 12, 2025
1.0 CME Credits for physicians until: December 8, 2026
1.0 CE Credit/Contact hours for nurses available until: April 8, 2027
Format: Non-interactive recorded webinar
Program Slides: Download
Target Audience
This activity is intended for hematologists-oncologists, medical oncologists, PAs, NPs, nurses, and other healthcare professionals engaged in the care of patients with Chronic Lymphocytic Leukemia (CLL).
Description
This webinar will provide a clinical update on chronic lymphocytic leukemia (CLL). Expert faculty will review the latest therapies, including BTK inhibitors and CAR T-cell therapy, share guidance on patient selection, and discuss strategies for treatment management, toxicity monitoring, and long-term survivorship care.
Learning Objectives
After completing this activity, the participant should be better able to:
- Explain treatment options including an overview of the latest developments in therapy
- Identify patients who are candidates for newly approved therapies including BTK inhibitors, alone or in combination, and CAR T-cell therapy
- Explain the HCP’s role in preparing the patient for therapy, administering treatment, monitoring for and managing side effects
- Discuss long-term follow up and survivorship care planning
Faculty
Inhye Ahn, MD
Associate Director, Chronic Lymphocytic Leukemia Center
Senior Physician
Assistant Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA
Lauren Berger, MPH
Blood Cancer United
Washington, DC
Corinne Hoffman, MS, APRN-CNP, AOCNP
Nurse Practitioner - Hematology Oncology
The James Comprehensive Cancer Center
The Ohio State University
Columbus, OH
Kerry Rogers, MD
Associate Professor
Division of Hematology, Department of Internal Medicine
The James Comprehensive Cancer Center
The Ohio State University
Columbus, OH
Continuing Education Information
In support of improving patient care, this activity has been planned and implemented by Blood Cancer United and Medical Learning Institute Inc. Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of Blood Cancer United under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
ILNA Recertification Points
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas: Care Continuum (OCN, CBCN, CPHON AOCNP) 0.75*, Foundations of Transplant (BMTCN) 0.5*, Late Post-Transplant Management and Education (BMTCN) 0.25*, Quality of Life (BMTCN) 0.25*, Transplant Process and Infusion (BMTCN) 0.75*, Treatment (OCN, CBCN, AOCNP, CPHON) 0.75*.
Total Points: 1
*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area. The total amount of points claimed may not exceed the total amount of nursing continuing professional development (NCPD) or CME awarded from this course and may only apply to the credential you are renewing. Please also note that nurses’ individual learning plans are linked to their credential’s test blueprint (content outline). Current ONCC test content outlines can be found on the ONCC website:
OCN® | https://www.oncc.org/files/2022OCNOutline.pdf
CPHON® | https://www.oncc.org/files/CPHONTestContentOutline.pdf
CBCN® | https://www.oncc.org/files/2022CBCNOutline.pdf
BMTCN® | https://www.oncc.org/files/2022BMTCNOutline.pdf
AOCNP® | https://www.oncc.org/files/2020AOCNPTestContentOutline.pdf
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Learners must participate in the entire CE activity, complete, and submit the evaluation form to earn credit. Once submitted, the certificate will be generated. If you have questions regarding the receipt of your certificate, please contact via email at [email protected].
Providers
This activity is provided by Blood Cancer United and Medical Learning Institute Inc.
Supporters
This activity is supported by independent medical education grants from AbbVie Inc. and AstraZeneca Pharmaceuticals.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: [email protected].